Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Sponsor
Alliance for Clinical Trials in Oncology (Other)
Overall Status
Completed
CT.gov ID
NCT00022087
Collaborator
National Cancer Institute (NCI) (NIH)
439
107
2
86
4.1
0

Study Details

Study Description

Brief Summary

RATIONALE: Zoledronate plus calcium and vitamin D may prevent bone loss in patients receiving adjuvant chemotherapy for breast cancer. It is not yet known which regimen is more effective in preventing bone loss.

PURPOSE: This randomized phase III trial is comparing two regimens of zoledronate plus calcium and vitamin D to see how well they work in preventing bone loss in women who are receiving adjuvant chemotherapy for breast cancer.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: calcium salts
  • Dietary Supplement: cholecalciferol
  • Drug: zoledronic acid
Phase 3

Detailed Description

OBJECTIVES:
  • Compare the bone mineral density in the lumbar spine after 12 and 36 months of therapy with zoledronate, calcium, and cholecalciferol (vitamin D) in women with breast cancer receiving adjuvant chemotherapy.

OUTLINE: This is a randomized, open-label, multicenter study. Patients are stratified according to intent to treat with tamoxifen (yes vs no) and node status (negative vs positive vs unknown [for patients receiving neoadjuvant therapy]). Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Beginning on the first day of adjuvant chemotherapy (or within 3 months after the first day), patients receive zoledronate IV over at least 15 minutes once every 3 months during months 1-24 and oral calcium and oral cholecalciferol (vitamin D) daily during months 1-36.

  • Arm II: Beginning on the first day of adjuvant chemotherapy (or within 3 months after the first day), patients receive oral calcium and oral vitamin D daily during months 1-36 and zoledronate IV over at least 15 minutes once every 3 months during months 13-36.

PROJECTED ACCRUAL: Approximately 400 patients (200 per treatment arm) will be accrued for this study within 24 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
439 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Phase III Trial of Intravenous Zoledronic Acid (Zometa) in the Prevention of Bone Loss in Localized Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure
Study Start Date :
Dec 1, 2001
Actual Primary Completion Date :
Mar 1, 2007
Actual Study Completion Date :
Feb 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Zoledronic acid initial tx

Zoledronic acid + calcium + Vit D for 2 years, followed by Calcium + vit D for 1 year

Dietary Supplement: calcium salts
1000 mg PO per day

Dietary Supplement: cholecalciferol
400 IU PO per day
Other Names:
  • Vitamin D
  • Drug: zoledronic acid
    4 mg IV infusion q 3 months, months 1-24 in Zoledronic acid initial tx arm and months 13-36 in calcium + vit D initial tx arm
    Other Names:
  • Zometa
  • Experimental: Calcium + Vit D initial Tx

    Calcium + vitamin D for 1 year followed by zoledronic acid + calcium + vit D for 2 years

    Dietary Supplement: calcium salts
    1000 mg PO per day

    Dietary Supplement: cholecalciferol
    400 IU PO per day
    Other Names:
  • Vitamin D
  • Drug: zoledronic acid
    4 mg IV infusion q 3 months, months 1-24 in Zoledronic acid initial tx arm and months 13-36 in calcium + vit D initial tx arm
    Other Names:
  • Zometa
  • Outcome Measures

    Primary Outcome Measures

    1. Bone mineral density in the lumbar spine [12 months from randomization]

    Secondary Outcome Measures

    1. Bone mineral density in the lumbar spine [36 months post randomization]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    DISEASE CHARACTERISTICS:
    • Histologically confirmed adenocarcinoma of the breast by fine needle aspirate, biopsy (tru-cut, core, stereotactic), lumpectomy, or modified radical mastectomy

    • Stage I-III (any T, any N, M0)

    • Stage IV due solely to supraclavicular node involvement allowed

    • Plan to use adjuvant chemotherapy* with or without adjuvant endocrine therapy*

    • Subsequent adjuvant hormonal therapy with an aromatase inhibitor allowed in women rendered postmenopausal by adjuvant chemotherapy NOTE: *Must be specified prior to study entry

    • Hormone receptor status:

    • Not specified

    PATIENT CHARACTERISTICS:
    Age:
    • 40 and over
    Sex:
    • Female
    Menopausal status:
    • See Disease Characteristics

    • Premenopausal, defined as actively menstruating or last menstrual period occurred within 6 months prior to study entry

    • Prior hysterectomy without bilateral oophorectomy and estradiol and follicle-stimulating hormone within premenopausal range prior to the initiation of chemotherapy allowed

    Performance status:
    • Not specified
    Life expectancy:
    • Not specified
    Hematopoietic:
    • Not specified
    Hepatic:
    • Not specified
    Renal:
    • Not specified
    Other:
    • Not pregnant or nursing

    • Negative pregnancy test

    • Fertile patients must use effective contraception

    PRIOR CONCURRENT THERAPY:
    Biologic therapy:
    • Not specified
    Chemotherapy:
    • See Disease Characteristics

    • No more than 3 months since prior adjuvant chemotherapy

    Endocrine therapy:
    • See Disease Characteristics
    Radiotherapy:
    • Not specified
    Surgery:
    • See Disease Characteristics

    • See Menopausal status

    Other:
    • No other concurrent bisphosphonates

    • No concurrent digoxin

    • No concurrent tetracycline

    • Concurrent neoadjuvant therapy allowed

    • Concurrent enrollment on therapeutic adjuvant clinical trials allowed provided the therapeutic trial does not preclude participation in this trial

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Arroyo Grande Community Hospital Arroyo Grande California United States 93420
    2 Rebecca and John Moores UCSD Cancer Center La Jolla California United States 92093-0658
    3 El Camino Hospital Mountain View California United States 94040
    4 Naval Medical Center - San Diego San Diego California United States 92134
    5 Veterans Affairs Medical Center - San Diego San Diego California United States 92161
    6 Kent General Hospital at Bayhealth Medical Center Dover Delaware United States 19901
    7 Beebe Medical Center Lewes Delaware United States 19958
    8 CCOP - Christiana Care Health Services Newark Delaware United States 19713
    9 St. Francis Hospital Wilmington Delaware United States 19805
    10 Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington District of Columbia United States 20007
    11 Washington Cancer Institute at Washington Hospital Center Washington District of Columbia United States 20010
    12 Sibley Memorial Hospital Washington District of Columbia United States 20016
    13 Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale Florida United States 33308
    14 Memorial Cancer Institute at Memorial Regional Hospital Hollywood Florida United States 33021
    15 Ella Milbank Foshay Cancer Center at Jupiter Medical Center Jupiter Florida United States 33458
    16 CCOP - Mount Sinai Medical Center Miami Beach Florida United States 33140
    17 Cancer Research Network, Incorporated Plantation Florida United States 33324
    18 Cleveland Clinic Florida - Weston Weston Florida United States 33331
    19 St. Joseph Medical Center Bloomington Illinois United States 61701
    20 Graham Hospital Canton Illinois United States 61520
    21 Memorial Hospital Carthage Illinois United States 62321
    22 University of Chicago Cancer Research Center Chicago Illinois United States 60637-1470
    23 Eureka Community Hospital Eureka Illinois United States 61530
    24 Galesburg Clinic Galesburg Illinois United States 61401
    25 Galesburg Cottage Hospital Galesburg Illinois United States 61401
    26 InterCommunity Cancer Center of Western Illinois Galesburg Illinois United States 61401
    27 Mason District Hospital Havana Illinois United States 62644
    28 Hopedale Medical Complex Hopedale Illinois United States 61747
    29 Kewanee Hospital Kewanee Illinois United States 61443
    30 La Grange Memorial Hospital La Grange Illinois United States 60525
    31 McDonough District Hospital Macomb Illinois United States 61455
    32 BroMenn Regional Medical Center Normal Illinois United States 61761
    33 Community Cancer Center Normal Illinois United States 61761
    34 Advocate Christ Medical Center Oak Lawn Illinois United States 60453-2699
    35 Community Hospital of Ottawa Ottawa Illinois United States 61350
    36 Cancer Treatment Center at Pekin Hospital Pekin Illinois United States 61554
    37 Proctor Hospital Peoria Illinois United States 61614
    38 CCOP - Illinois Oncology Research Association Peoria Illinois United States 61615
    39 Oncology/Hematology Associates of Central Illinois, P.C. Peoria Illinois United States 61615
    40 Methodist Medical Center of Illinois Peoria Illinois United States 61636
    41 OSF St. Francis Medical Center Peoria Illinois United States 61637
    42 Illinois Valley Community Hospital Peru Illinois United States 61354
    43 Perry Memorial Hospital Princeton Illinois United States 61356
    44 St. Margaret's Hospital Spring Valley Illinois United States 61362
    45 Valley Cancer Center Spring Valley Illinois United States 61362
    46 Elkhart General Hospital Elkhart Indiana United States 46515
    47 Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana United States 46350
    48 Suniti Medical Corporation Merrillville Indiana United States 46410
    49 CCOP - Northern Indiana CR Consortium South Bend Indiana United States 46601
    50 Memorial Hospital of South Bend South Bend Indiana United States 46601
    51 Saint Joseph Regional Medical Center South Bend Indiana United States 46617
    52 Hematology Oncology Associates of the Quad Cities Bettendorf Iowa United States 52722
    53 Iowa Blood and Cancer Care Cedar Rapids Iowa United States 52402
    54 St. Luke's Hospital Cedar Rapids Iowa United States 52402
    55 Mercy Regional Cancer Center at Mercy Medical Center Cedar Rapids Iowa United States 52403
    56 Central Maine Medical Center Lewiston Maine United States 04240
    57 Maine Center for Cancer Medicine and Blood Disorders - Scarborough Scarborough Maine United States 04074
    58 Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland United States 21201
    59 Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center Baltimore Maryland United States 21237
    60 Union Hospital Cancer Center at Union Hospital Elkton MD Maryland United States 21921
    61 Sturdy Memorial Hospital Attleboro Massachusetts United States 02703
    62 Massachusetts General Hospital Cancer Center Boston Massachusetts United States 02114
    63 Brigham and Women's Hospital Boston Massachusetts United States 02115
    64 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts United States 02115
    65 Faulkner Hospital Boston Massachusetts United States 02130
    66 Bethke Cancer Center at Emerson Hospital Concord Massachusetts United States 01742
    67 Lowell General Hospital Lowell Massachusetts United States 01854
    68 Fairview University Medical Center - University Campus Minneapolis Minnesota United States 55455
    69 Saint Luke's Hospital Chesterfield Missouri United States 63017
    70 CCOP - Kansas City Kansas City Missouri United States 64131
    71 Siteman Cancer Center at Barnes-Jewish Hospital St Louis Missouri United States 63110
    72 Missouri Baptist Cancer Center St. Louis Missouri United States 63131
    73 Missouri Cancer Care, P. C. - Wentzville Wentzville Missouri United States 63385
    74 Methodist Cancer Center at Methodist Hospital - Omaha Omaha Nebraska United States 68114
    75 University Medical Center of Southern Nevada Las Vegas Nevada United States 89102
    76 CCOP - Nevada Cancer Research Foundation Las Vegas Nevada United States 89106
    77 New Hampshire Oncology-Hematology, PA - Hooksett Hooksett New Hampshire United States 03106
    78 Lakes Region General Hospital Laconia New Hampshire United States 03246
    79 Elliot Regional Cancer Center Manchester New Hampshire United States 03103
    80 Oncology Center at St. Joseph Hospital Nashua New Hampshire United States 03060
    81 Jersey City Medical Center at Liberty Health Jersey City New Jersey United States 07302
    82 Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees New Jersey United States 08043
    83 Roswell Park Cancer Institute Buffalo New York United States 14263-0001
    84 Memorial Sloan-Kettering Cancer Center New York New York United States 10021
    85 Nalitt Cancer Institute at Staten Island University Hospital Staten Island New York United States 10305
    86 CCOP - Hematology-Oncology Associates of Central New York Syracuse New York United States 13057
    87 Community General Hospital of Greater Syracuse Syracuse New York United States 13215
    88 Faxton Regional Cancer Center Utica New York United States 13502
    89 Mission Hospitals - Memorial Campus Asheville North Carolina United States 28801
    90 Duke Comprehensive Cancer Center Durham North Carolina United States 27710
    91 Wayne Memorial Hospital, Incorporated Goldsboro North Carolina United States 27534
    92 Pardee Memorial Hospital Hendersonville North Carolina United States 28791
    93 Lenoir Memorial Cancer Center Kinston North Carolina United States 28501
    94 Moore Regional Community Hospital Comprehensive Cancer Center Pinehurst North Carolina United States 28374
    95 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus Ohio United States 43210-1240
    96 Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh Pennsylvania United States 15224-1791
    97 Rhode Island Hospital Providence Rhode Island United States 02903
    98 Women and Infants Hospital of Rhode Island Providence Rhode Island United States 02905
    99 Miriam Hospital at Lifespan Providence Rhode Island United States 02906
    100 CCOP - Greenville Greenville South Carolina United States 29615
    101 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas United States 75390
    102 Southwestern Vermont Regional Cancer Center Bennington Vermont United States 05201
    103 Mountainview Medical Berlin Vermont United States 05602
    104 Fletcher Allen Health Care - University Health Center Campus Burlington Vermont United States 05401
    105 Community Cancer Center at Rutland Regional Medical Center Rutland Vermont United States 05701
    106 Danville Regional Medical Center Danville Virginia United States 24541
    107 St. Mary's Regional Cancer Center at St. Mary's Medical Center Huntington West Virginia United States 25702

    Sponsors and Collaborators

    • Alliance for Clinical Trials in Oncology
    • National Cancer Institute (NCI)

    Investigators

    • Study Chair: Charles L. Shapiro, MD, Ohio State University Comprehensive Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alliance for Clinical Trials in Oncology
    ClinicalTrials.gov Identifier:
    NCT00022087
    Other Study ID Numbers:
    • CALGB-79809
    • U10CA031946
    • CALGB-79809
    • NCI-P01-0184
    • CDR0000068781
    First Posted:
    Jan 27, 2003
    Last Update Posted:
    Jul 19, 2016
    Last Verified:
    Jul 1, 2016

    Study Results

    No Results Posted as of Jul 19, 2016